View in EDS HTML Full Text PDF Full Text

Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.

Saved in:
Bibliographic Details
Title: Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Authors: Ryvlin P; Department of Clinical Neurosciences, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland., Dimova S; UCB Pharma, Brussels, Belgium., Elmoufti S; UCB Pharma, Morrisville, North Carolina, USA., Floricel F; UCB Pharma, Monheim am Rhein, Germany., Laloyaux C; UCB Pharma, Brussels, Belgium., Nondonfaz X; UCB Pharma, Braine-l'Alleud, Belgium., Biton V; Arkansas Epilepsy Program PA, Little Rock, Arkansas, USA.
Source: Epilepsia [Epilepsia] 2022 Aug; Vol. 63 (8), pp. 2024-2036. Date of Electronic Publication: 2022 Jun 10.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35582748
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ryvlin+P%22">Ryvlin P</searchLink>; Department of Clinical Neurosciences, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dimova+S%22">Dimova S</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Elmoufti+S%22">Elmoufti S</searchLink>; UCB Pharma, Morrisville, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Floricel+F%22">Floricel F</searchLink>; UCB Pharma, Monheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Laloyaux+C%22">Laloyaux C</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Nondonfaz+X%22">Nondonfaz X</searchLink>; UCB Pharma, Braine-l'Alleud, Belgium.<br /><searchLink fieldCode="AU" term="%22Biton+V%22">Biton V</searchLink>; Arkansas Epilepsy Program PA, Little Rock, Arkansas, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222983306R%22">Epilepsia</searchLink> [Epilepsia] 2022 Aug; Vol. 63 (8), pp. 2024-2036. <i>Date of Electronic Publication: </i>2022 Jun 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2983306R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-1167 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200139580%22">00139580 </searchLink><i>NLM ISO Abbreviation: </i>Epilepsia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35582748
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/epi.17304
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2024
    Titles:
      – TitleFull: Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ryvlin P
      – PersonEntity:
          Name:
            NameFull: Dimova S
      – PersonEntity:
          Name:
            NameFull: Elmoufti S
      – PersonEntity:
          Name:
            NameFull: Floricel F
      – PersonEntity:
          Name:
            NameFull: Laloyaux C
      – PersonEntity:
          Name:
            NameFull: Nondonfaz X
      – PersonEntity:
          Name:
            NameFull: Biton V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1528-1167
          Numbering:
            – Type: volume
              Value: 63
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Epilepsia
              Type: main
ResultId 1